Skip to main content
Top
Published in: Abdominal Radiology 6/2008

01-11-2008

Assessment of Crohn’s disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations

Authors: Roberto Malagò, Riccardo Manfredi, Luigi Benini, Gianni D’Alpaos, Roberto Pozzi Mucelli

Published in: Abdominal Radiology | Issue 6/2008

Login to get access

Abstract

Background

The aim of our study was to evaluate the accuracy of magnetic resonance imaging (MRI) in evaluating Crohn’s disease (CD) activity compared to clinical/laboratory data.

Methods

Ninety-three consecutive patients with CD were prospectively studied by MR imaging, before and after Gadolinium chelates administration, with use of a biphasic endoluminal contrast agent. MR image analysis included: number of lesions, presence/absence of bowel stenosis, upstream bowel dilation, wall thickness, presence of enhancement, enhancement pattern, presence/absence of comb sign, lymph nodes, and perianal fistulas/abscesses. Clinical evaluation was performed by means of Harvey & Bradshaw Index. Acute-phase reactants were considered standard of reference to monitor biological activity (BA). MR imaging findings were compared with clinical and laboratory data.

Results

MR image analysis detected: In 96 exams multiple lesions in 16, 1 in 50; no lesions in 30; stenosis in 52; dilatation in 28; wall thickening in 59; significant enhancement in 57; layered pattern in 50; comb sign in 37; enlarged lymph nodes in 16; fibro-fatty proliferation in 40; fistulas in 9.

Conclusions

MRI is able to depict morphological changes and is helpful in assessing Crohn’s inflammatory disease.
Literature
1.
go back to reference Best W, Becktel J, Singleton J, Kern F (1976) Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444PubMed Best W, Becktel J, Singleton J, Kern F (1976) Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444PubMed
2.
go back to reference Best WR (2006) Predicting the Crohn’s disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 12:304–310PubMedCrossRef Best WR (2006) Predicting the Crohn’s disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 12:304–310PubMedCrossRef
3.
go back to reference Jorgensen LG, Fredholm L, Hyltoft Petersen P, et al. (2005) How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med 43:403–411PubMedCrossRef Jorgensen LG, Fredholm L, Hyltoft Petersen P, et al. (2005) How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med 43:403–411PubMedCrossRef
4.
go back to reference Koh DM, Miao Y, Chinn RJ, et al. (2001) MR imaging evaluation of the activity of Crohn’s disease. Am J Roentgenol 177:1325–1332 Koh DM, Miao Y, Chinn RJ, et al. (2001) MR imaging evaluation of the activity of Crohn’s disease. Am J Roentgenol 177:1325–1332
5.
go back to reference Meyers MA, McGuire PV (1995) Spiral CT demonstration of hypervascularity in Crohn disease: “vascular jejunization of the ileum” or the “comb sign”. Abdom Imaging 20:327–332PubMedCrossRef Meyers MA, McGuire PV (1995) Spiral CT demonstration of hypervascularity in Crohn disease: “vascular jejunization of the ileum” or the “comb sign”. Abdom Imaging 20:327–332PubMedCrossRef
6.
go back to reference Travis SP, Stange EF, Lemann M, et al. (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut 55(suppl 1):i16–i35PubMedCrossRef Travis SP, Stange EF, Lemann M, et al. (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut 55(suppl 1):i16–i35PubMedCrossRef
7.
go back to reference Naber AH, de Jong DJ (2003) Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. Neth J Med 61:105–110PubMed Naber AH, de Jong DJ (2003) Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. Neth J Med 61:105–110PubMed
8.
go back to reference Singleton JW (1987) Clinical activity assessment in inflammatory bowel disease. Dig Dis Sci 32:42S–45SPubMedCrossRef Singleton JW (1987) Clinical activity assessment in inflammatory bowel disease. Dig Dis Sci 32:42S–45SPubMedCrossRef
9.
go back to reference Solem CA, Loftus EV, Tremaine WJ, et al. (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11:707–712PubMedCrossRef Solem CA, Loftus EV, Tremaine WJ, et al. (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11:707–712PubMedCrossRef
10.
go back to reference Chernish SM, Maglinte DD, O’Connor K (1992) Evaluation of the small intestine by enteroclysis for Crohn’s disease. Am J Gastroenterol 87:696–701PubMed Chernish SM, Maglinte DD, O’Connor K (1992) Evaluation of the small intestine by enteroclysis for Crohn’s disease. Am J Gastroenterol 87:696–701PubMed
11.
go back to reference Maglinte DD, Chernish SM, Kelvin FM, et al. (1992) Crohn disease of the small intestine: accuracy and relevance of enteroclysis. Radiology 184:541–545PubMed Maglinte DD, Chernish SM, Kelvin FM, et al. (1992) Crohn disease of the small intestine: accuracy and relevance of enteroclysis. Radiology 184:541–545PubMed
12.
go back to reference Laghi A, Paolantonio P, Catalano C, et al. (2003) MR imaging of the small bowel using polyethylene glycol solution as an oral contrast agent in adults and children with celiac disease: preliminary observations. Am J Roentgenol 180:191–194 Laghi A, Paolantonio P, Catalano C, et al. (2003) MR imaging of the small bowel using polyethylene glycol solution as an oral contrast agent in adults and children with celiac disease: preliminary observations. Am J Roentgenol 180:191–194
13.
go back to reference Maccioni F, Viscido A, Broglia L, et al. (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228PubMedCrossRef Maccioni F, Viscido A, Broglia L, et al. (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228PubMedCrossRef
14.
go back to reference Maglinte DD, Siegelman ES, Kelvin FM (2000) MR enteroclysis: the future of small-bowel imaging? Radiology 215:639–641PubMed Maglinte DD, Siegelman ES, Kelvin FM (2000) MR enteroclysis: the future of small-bowel imaging? Radiology 215:639–641PubMed
15.
go back to reference Giovagnoni A, Fabbri A, Maccioni F (2002) Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging 27:367–375PubMedCrossRef Giovagnoni A, Fabbri A, Maccioni F (2002) Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging 27:367–375PubMedCrossRef
16.
go back to reference Hahn PF (1991) Advances in contrast-enhanced MR imaging. Gastrointestinal contrast agents. Am J Roentgenol 156:252–254 Hahn PF (1991) Advances in contrast-enhanced MR imaging. Gastrointestinal contrast agents. Am J Roentgenol 156:252–254
17.
go back to reference Prassopoulos P, Papanikolaou N, Grammatikakis J, et al. (2001) MR enteroclysis imaging of Crohn disease. Radiographics 21 Spec No:S161–S172PubMed Prassopoulos P, Papanikolaou N, Grammatikakis J, et al. (2001) MR enteroclysis imaging of Crohn disease. Radiographics 21 Spec No:S161–S172PubMed
18.
go back to reference Broglia L, Gigante P, Papi C, et al. (2003) Magnetic resonance enteroclysis imaging in Crohn’s disease. Radiol Med (Torino) 106:28–35 Broglia L, Gigante P, Papi C, et al. (2003) Magnetic resonance enteroclysis imaging in Crohn’s disease. Radiol Med (Torino) 106:28–35
Metadata
Title
Assessment of Crohn’s disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations
Authors
Roberto Malagò
Riccardo Manfredi
Luigi Benini
Gianni D’Alpaos
Roberto Pozzi Mucelli
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 6/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-008-9368-8

Other articles of this Issue 6/2008

Abdominal Radiology 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.